Baidu
map

中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版)

2017-10-20 肾脏病相关专家小组(统称) Chin Med J (Engl). 2017 Oct 20;130(20):2473-2488.

我国高尿酸血症(hypemricemia,HUA)的患病率逐年增高,并呈年轻化趋势,已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外,还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识,各有侧重。本共识参照系统医学模式,邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成,是我国HUA相

中文标题:

中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版)

英文标题:

Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases

发布日期:

2017-10-20

简要介绍:

我国高尿酸血症(hypemricemia,HUA)的患病率逐年增高,并呈年轻化趋势,已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外,还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识,各有侧重。本共识参照系统医学模式,邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成,是我国HUA相关疾病的首个多学科专家共识,旨在推动多学科协作,指导和规范HUA相关疾病的临床实践。

 

拓展指南:高尿酸血症相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版))] GetToolGuiderByIdResponse(projectId=1, id=01f4f1c00151a207, title=中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版), enTitle=Chinese Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hyperuricemia and Related Diseases, guiderFrom=Chin Med J (Engl). 2017 Oct 20;130(20):2473-2488., authorId=null, author=, summary=我国高尿酸血症(hypemricemia,HUA)的患病率逐年增高,并呈年轻化趋势,已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外,还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识,各有侧重。本共识参照系统医学模式,邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成,是我国HUA相, cover=, journalId=null, articlesId=null, associationId=283, associationName=肾脏病相关专家小组(统称), associationIntro=本制定者非特指某个专家小组。, copyright=0, guiderPublishedTime=Fri Oct 20 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>我国高尿酸血症(hypemricemia,HUA)的患病率逐年增高,并呈年轻化趋势,已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外,还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。既往部分学科已从本专业出发制定了相关临床指南或专家共识,各有侧重。本共识参照系统医学模式,邀请风湿免疫、肾脏、内分泌代谢、心血管、神经、泌尿和中医科等学科专家共同讨论、制定而成,是我国HUA相关疾病的首个多学科专家共识,旨在推动多学科协作,指导和规范HUA相关疾病的临床实践。 </P> <P> </P>拓展指南:<strong>与<font color=red>高尿酸血症</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=c90d11c001a89993" title="中国慢性肾脏病患者合并高尿酸血症诊治专家共识" target=_blank>中国慢性肾脏病患者合并高尿酸血症诊治专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=49edf1c001a831fd" title="中国高尿酸血症相关疾病诊疗多学科专家共识" target=_blank>中国高尿酸血症相关疾病诊疗多学科专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=e87e71c001a66100" title="中国肾脏疾病高尿酸血症诊治的实践指南(2017版)" target=_blank>中国肾脏疾病高尿酸血症诊治的实践指南(2017版)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=a756b1c00119800b" title="高尿酸血症和痛风治疗的中国专家共识" target=_blank>高尿酸血症和痛风治疗的中国专家共识</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=896b71c0010296d7" title="2013高尿酸血症和痛风治疗中国专家共识-期刊版" target=_blank>2013高尿酸血症和痛风治疗中国专家共识-期刊版</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E9%AB%98%E5%B0%BF%E9%85%B8%E8%A1%80%E7%97%87" target=_blank>有关高尿酸血症更多指南</a></ul>, tagList=[TagDto(tagId=4057, tagName=高尿酸血症)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7739, appHits=586, showAppHits=23, pcHits=5100, showPcHits=2902, likes=155, shares=22, comments=6, approvalStatus=1, publishedTime=Wed Nov 01 21:17:18 CST 2017, publishedTimeString=2017-10-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Nov 01 21:17:18 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:22:07 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版))])
中国高尿酸血症与相关疾病诊疗多学科专家共识(英文版)
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的,更有利于学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2021-08-24 ms4000002107220844

    希望能下载到中文版的,更有利于学习!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的,更有利于学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2021-08-24 ms4000002107220844

    开卷有益!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的,更有利于学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2018-08-24 鹏远

    学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的,更有利于学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-12-04 liuweigang

    学习.了解.了解.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1010879, encodeId=253f10108e9fd, content=希望能下载到中文版的,更有利于学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:14:14 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010875, encodeId=7ca310108e5f7, content=开卷有益!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7fe5582820, createdName=ms4000002107220844, createdTime=Tue Aug 24 09:09:30 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=340544, encodeId=77c534054484, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f1ba2215278, createdName=鹏远, createdTime=Fri Aug 24 11:34:19 CST 2018, time=2018-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=266735, encodeId=391e266e355a, content=学习.了解.了解., beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Mon Dec 04 12:59:29 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263911, encodeId=b36c26391103, content=学习了.不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/07/d51783575d8d90eaa8b668d568aa6e50.jpg, createdBy=909f109204, createdName=liuweigang, createdTime=Fri Nov 24 09:52:08 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-11-24 liuweigang

    学习了.不错

    0

Baidu
map
Baidu
map
Baidu
map